Lessons from neurolathyrism: A disease of the past & the future of Lathyrus sativus (Khesari dal)

Indian Journal of Medical Research

Volumn 138, Issue JUL 2013, 2013, Pages 32-37

  Singh, Suryas S ^a   Rao, S L N ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Functional food; Homoarginine; Hypertension; Hypoxia inducible factor; Khesari dal; L ODAP; Neurolathyrism; Nitric oxide

Indexed keywords

3 OXALYLAMINOALANINE; HOMOARGININE; HYPOXIA INDUCIBLE FACTOR 1; NEUROTOXIN; PROTEIN KINASE C; TYROSINE AMINOTRANSFERASE;

EXCITOTOXICITY; HUMAN; INTROSPECTION; LATHYRISM; LATHYRUS SATIVUS; METABOLISM; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PLANT SEED; REVIEW;

AMINO ACIDS, DIAMINO; ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDIA; LATHYRISM; LATHYRUS; PROTEIN KINASE C;

EID: 84881080762     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Dwivedi MP, Prasad BG. An epidemiological study of lathyrism in the district of Rewa, Madhya Pradesh. Indian J Med Res 1964; 52: 81-116.
2. Getahun H, Mekonnen A, TekleHaimanot R, Lambein F. Epidemic of neurolathyrism in Ethiopia. Lancet 1999; 354: 306-7.
3. Misra UK, Sharma VP, Singh VP. Clinical aspects of neurolathyrism in Unnao, India. Paraplegia 1993; 31: 249-54.
4. Getahun H, Lambein F, Vanhoorne M, Van der Stuyft P. Food-aid cereals to reduce neurolathyrism related to grass-pea preparations during famine. Lancet 2003; 362: 1808-10.
5. Rao SL, Adiga PR, Sarma PS. The isolation and characterization of β-N- oxalyl-L-α, β-diaminopropionic acid, a neurotoxin from the seeds of Lathyrus sativus. Biochemistry 1964; 3: 432-6.
6. Rao SL. Entry of β-N-oxalyl-L-α, β-diaminopropionic acid, the Lathyrus sativus neurotoxin into the central nervous system of the adult rat, chick and the rhesus monkey. J Neurochem 1978; 30: 1467-70.
7. Lambein F, Kuo YH, Kusama-Eguchi K, Ikegami F. 3-N-oxalyl-L-2, 3-diaminopropionic acid, a multifunctional plant metabolite of toxic reputation. ARKIVOC 2007; 9: 45-52.
8. Rao SL, Sarma PS, Mani KS, Raghunatha Rao TR, Sriramachari S. Experimental neurolathyrism in monkeys. Nature 1967; 214: 610-1.
9. National Institute of Nutrition (ICMR) Annual Report. Hyderabad: NIN; 1977. p. 46-8.
10. Spencer PS, Roy DN, Ludolph A, Hugon J, Dwivedi MP, Schaumburg HH. Lathyrism: evidence for role of the neuroexcitatory amino acid BOAA. Lancet 1986; 2: 1066-7.
11. Kusama-Eguchi K, Yamazaki Y, Ueda T, Suda A, Hirayama Y, Ikegami F, et al. Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord.J Comp Neurol 2010; 518: 928-42.
12. Enneking D. The nutritive value of grasspea (Lathyrus sativus) and allied species, their toxicity to animals and the role of malnutrition in neurolathyrism. Food Chem Toxicol 2011; 49: 694-709.
13. Shasi Vardhan K, Pratap Rudra MP, Rao SL. Inhibition of tyrosine aminotransferase by β -N-oxalyl-L-α, β-diaminopropionic acid, the Lathyrus sativus neurotoxin.J Neurochem 1997; 68: 2477-84.
14. Lambein F, Haque R, Khan JK, Kebede N, Kuo YH. From soil to brain: zinc deficiency increases the neurotoxicity of Lathyrus sativus and may affect the susceptibility for the motorneurone disease neurolathyrism. Toxicon 1994; 32: 461-6.
15. Watkins JC, Curtis DR, Biscoe TJ. Central effects of β-N-oxalyl-α, β-diaminopropionic acid and other lathyrus factors. Nature 1966; 211: 637.
16. Bridges RJ, Stevens DR, Kahle JS, Nunn PB, Kadri M, Cotman CW. Structure function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that β- L-ODAP is a selective non NMDA agonist.J Neurosci 1989; 9: 2073-9.
17. Jain RK, Junaid MA, Rao SL. Receptor interactions of β-N-oxalyl-L-α, β-diaminopropionic acid, the Lathyrus sativus putative excitotoxin, with synaptic membrances. Neurochem Res 1998; 23: 1191-6.
18. Omelchenko IA, Jain RK, Junaid MA, Rao SL, Allen CN. Neurotoxic potential of three structural analogues of β-N-oxalyl-α, β-diaminopropanoic acid (β-ODAP). Neurochem Res 1999; 24: 791-7.
19. Karamyan VT. Speth RC. Animal models of BMAA neurotoxicity: a critical review. Life Sci 2008; 82: 233-46.
20. Van Moorhem M, Lambein F, Leybaert L. Unraveling the mechanism of β-N-oxalyl-α, β-diaminopropionic acid (β-ODAP) induced excitotoxicity and oxidative stress, relevance for neurolathyrism prevention. Food Chem Toxicol 2011; 49: 550-5.
21. Sriram K, Shankar SK, Boyd MR, Ravindranath V. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration. J Neurosci 1998; 18: 10287-96.
22. Sabri MI, Lystrup B, Roy DN, Spencer PS: Action of β-N-oxalylamino-L-alanine on mouse brain NADH-dehydrogenase activity. J Neurochem 1995; 65: 1842-8.
23. Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GJ, Labruyere J. Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.Exp Neurol 1990; 108: 269-72.
24. Cha JH, Dure LS IV, Sakurai SY, Penney JB, Young AB. 2, 4, 5-Trihydroxyphenylalanine (6-hydroxy-dopa) displaces [3H]AMPA binding in rat striatum. Neurosci Lett 1991; 132: 55-8.
25. Jyothi P, Pratap Rudra M, Rao SL. In vivo metabolism of β-N-oxalyl-L-α, β-diaminopropionic acid: the Lathyrus sativus neurotoxin in experimental animals. Nat Toxins 1998; 6: 189-95.
26. Pratap Rudra M, Singh MR, Junaid MA, Jyothi P, Rao SL. Metabolism of dietary ODAP in humans may be responsible for the low incidence of neurolathyrism. Clin Biochem 2004; 37: 318-22.
27. Kusama-Eguchi K, Yoshino N, Minoura A, Watanabe K, Kusama T, Lambein F, et al. Sulfur amino acids deficiency caused by grass pea diet plays an important role in the toxicity of L-β-ODAP by increasing the oxidative stress: studies on a motor neuron cell line. Food Chem Toxicol 2011; 49: 636-43.
28. Session-IV. Lathyrus: The golden pulse of the future. International conference on "Recent trends in Lathyrus sativus research" November 8-9, National Institute of Nutrition (ICMR), 2012, Hyderabad, India.
29. Girma D, Korbu L. Genetic improvement of grass pea (Lathyrus sativus) in Ethiopia:an unfulfilled promise. Plant Breed 2012; 131: 231-6.
30. Singh RM, Pratap Rudra M, Rao SL, Singh SS. In vitro activation of protein kinase C by β-N-Oxalyl-L-α, β -diaminopropionic acid, the Lathyrus sativus neurotoxin. Neurochem Res 2004; 29: 1343-8.
31. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70: 1469-80.
32. Jammulamadaka N, Burgula S, Medisetty R, Ilavazhagan G, Rao SL, Singh SS. β-N-oxalyl-L-α, β-diaminopropionic acid regulates mitogen-activated protein kinase signaling by down-regulation of phosphatidylethanolamine-binding protein 1.J Neurochem 2011; 118: 176-86.
33. Ziello JE, Jovin IS, Huang Y. Hypoxia inducible factor (HIF-1) regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med 2007; 80: 51-60.
34. Nelson TJ, Alkon DL. Neuroprotective versus tumorigenic protein kinase C activators. Trends Biochem Sci 2009; 34: 136-45.
35. Rao SL, Ramachandran LK, Adiga PR. The isolation and characterization of L-homoarginine from the seeds ofLathyrus sativus. Biochemistry 1963; 2: 298-300.
36. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related toflow-mediated vasodilatation. Circ J 2008; 72: 1879-84.
37. Jyothi P, Rao SLN. Sustained nitric oxide generation with L-homoarginine. Res Comm Biochem Cell Mol Biol 1999; 3: 223-32.
38. The science of NO. In: Ignarro LJ, editor. No more heart disease: how nitric oxide can prevent-even reverse-heart disease and stroke. New York: St. Martin's Press; 2005.
39. Marz W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, et al. Homoarginine, cardiovascular risk and mortality. Circulation 2010; 122: 967-75.
40. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, et al. Homoarginine, heart failure and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011; 33: 852-9.
41. Lin CW, Fishman WH. L-Homoarginine. An organ-specific uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem 1972; 247: 3082-7.
42. Pilz S, Meinitzer A, Tomaschitz A, Kienreich K, Fahrleitner-Rammer A, Drechsler C, et al. Homoarginine deficiency is associated with increased bone turnover. Osteoporosis Int 2012; 23: 2731-2.
43. Henningsson R, Lundquist I. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production. Am J Physiol 1998; 275: E500-6.
44. Rao SL. A look at the brighter facets of β-N-oxalyl-L-α, β-diaminopropionic acid, homoarginine and the grass pea. Food Chem Toxicol 2011; 49: 620-2.
45. Gang Zhao, Fourth Military Medical University. Notoginseng factor in preparing medicine for treating neurodegenerative diseases drugs Application of dencichine in preparation of medicament for treating neurodegenerative diseases. China Patent, CN 102579418A, July 2012,
46. Compositions and methods for treating hemorrhagic condition. United State Patent. 20110160307, June 2011.